Axonics, Inc. (AXNX)
USD 70.98
(N/A%)
USD 70.98
(N/A%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 82.35 Million USD | -7.68% |
| 2022 | 89.21 Million USD | 36.19% |
| 2021 | 65.5 Million USD | 19.46% |
| 2020 | 54.83 Million USD | 48.93% |
| 2019 | 36.81 Million USD | 28.6% |
| 2018 | 28.63 Million USD | -55.79% |
| 2017 | 64.76 Million USD | 37.4% |
| 2016 | 47.13 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 104.02 Million USD | 17.59% |
| 2024 Q1 | 88.46 Million USD | 7.41% |
| 2023 Q3 | 50.12 Million USD | 50.61% |
| 2023 FY | 82.35 Million USD | -7.68% |
| 2023 Q1 | 89.08 Million USD | -0.14% |
| 2023 Q2 | 33.28 Million USD | -62.64% |
| 2023 Q4 | 82.35 Million USD | 64.3% |
| 2022 Q2 | 76.36 Million USD | 22.89% |
| 2022 FY | 89.21 Million USD | 36.19% |
| 2022 Q4 | 89.21 Million USD | 7.8% |
| 2022 Q3 | 82.76 Million USD | 8.38% |
| 2022 Q1 | 62.13 Million USD | -5.14% |
| 2021 Q2 | 61.24 Million USD | -46.66% |
| 2021 Q1 | 114.81 Million USD | 109.38% |
| 2021 FY | 65.5 Million USD | 19.46% |
| 2021 Q4 | 65.5 Million USD | -8.02% |
| 2021 Q3 | 71.21 Million USD | 16.28% |
| 2020 Q3 | 53.77 Million USD | 5.77% |
| 2020 Q2 | 50.84 Million USD | 13.22% |
| 2020 Q1 | 44.9 Million USD | 21.96% |
| 2020 FY | 54.83 Million USD | 48.93% |
| 2020 Q4 | 54.83 Million USD | 1.98% |
| 2019 Q3 | 33.85 Million USD | 5.67% |
| 2019 Q4 | 36.81 Million USD | 8.75% |
| 2019 Q2 | 32.03 Million USD | 14.05% |
| 2019 Q1 | 28.09 Million USD | -1.88% |
| 2019 FY | 36.81 Million USD | 28.6% |
| 2018 Q3 | 100.13 Million USD | 4.14% |
| 2018 Q1 | - USD | -100.0% |
| 2018 FY | 28.63 Million USD | -55.79% |
| 2018 Q4 | 28.63 Million USD | -71.41% |
| 2018 Q2 | 96.15 Million USD | 0.0% |
| 2017 Q4 | 64.76 Million USD | 0.0% |
| 2017 FY | 64.76 Million USD | 37.4% |
| 2017 Q1 | - USD | 0.0% |
| 2016 FY | 47.13 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -60.688% |
| BrainsWay Ltd. | 15.31 Million USD | -437.802% |
| Cerus Corporation | 144.3 Million USD | 42.927% |
| Envoy Medical, Inc. | 9.4 Million USD | -775.973% |
| electroCore, Inc. | 8.94 Million USD | -820.727% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -1441.726% |
| IceCure Medical Ltd | 4.24 Million USD | -1839.228% |
| Inogen, Inc. | 121.38 Million USD | 32.149% |
| OrthoPediatrics Corp. | 72.56 Million USD | -13.503% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -178.419% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -2488.324% |
| MaxCyte, Inc. | 36.1 Million USD | -128.097% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -4356.873% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -19265.784% |
| Orthofix Medical Inc. | 326.58 Million USD | 74.782% |
| PAVmed Inc | 57.13 Million USD | -44.143% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -223.446% |
| RxSight, Inc. | 22.18 Million USD | -271.187% |
| Sight Sciences, Inc. | 46.43 Million USD | -77.36% |
| SI-BONE, Inc. | 61.05 Million USD | -34.904% |
| TELA Bio, Inc. | 59.16 Million USD | -39.198% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 27.736% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -698.13% |
| Acutus Medical, Inc. | 54.83 Million USD | -50.183% |
| Talis Biomedical Corporation | 29.22 Million USD | -181.82% |
| Spectral AI, Inc. | 12.4 Million USD | -564.132% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -256.008% |
| CVRx, Inc. | 39.28 Million USD | -109.661% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -588.731% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -3290.236% |
| Bioventus Inc. | 589.79 Million USD | 86.036% |
| Venus Concept Inc. | 107.1 Million USD | 23.103% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -59.416% |
| LivaNova PLC | 1.15 Billion USD | 92.85% |
| 908 Devices Inc. | 37.49 Million USD | -119.683% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 88.293% |
| Nemaura Medical Inc. | 26.37 Million USD | -212.233% |
| NeuroPace, Inc. | 86.99 Million USD | 5.331% |
| LENSAR, Inc. | 22.4 Million USD | -267.526% |
| Apyx Medical Corporation | 52.31 Million USD | -57.42% |
| Cutera, Inc. | 518.12 Million USD | 84.104% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -180.82% |
| BioSig Technologies, Inc. | 4.68 Million USD | -1657.93% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -41.105% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -283.279% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 96.246% |
| Outset Medical, Inc. | 190.91 Million USD | 56.861% |
| IRIDEX Corporation | 24.91 Million USD | -230.573% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 33.563% |
| IRadimed Corporation | 20.73 Million USD | -297.18% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -4819.892% |
| INVO Bioscience, Inc. | 19.99 Million USD | -311.899% |
| Telesis Bio, Inc. | 40.87 Million USD | -101.5% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -101.909% |
| Varex Imaging Corporation | 668.6 Million USD | 87.682% |
| Quipt Home Medical Corp. | 136.29 Million USD | 39.572% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2205.683% |
| Pulmonx Corporation | 60.63 Million USD | -35.825% |
| Dynatronics Corporation | 11.78 Million USD | -599.136% |
| Modular Medical, Inc. | 2.27 Million USD | -3524.956% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1926.55% |
| Semler Scientific, Inc. | 6.27 Million USD | -1213.541% |
| InMode Ltd. | 75.91 Million USD | -8.49% |
| Bruker Corporation | 2.83 Billion USD | 97.097% |
| Cytosorbents Corporation | 29.98 Million USD | -174.663% |
| DexCom, Inc. | 4.19 Billion USD | 98.037% |
| Align Technology, Inc. | 2.45 Billion USD | 96.643% |
| Viveve Medical, Inc. | 10.84 Million USD | -659.279% |
| ZimVie Inc. | 795.85 Million USD | 89.651% |
| Movano Inc. | 5.97 Million USD | -1279.086% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 21.267% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -19265.784% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -588.731% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 87.112% |
| Profound Medical Corp. | 12.66 Million USD | -550.244% |
| Insulet Corporation | 1.85 Billion USD | 95.561% |
| enVVeno Medical Corporation | 2.43 Million USD | -3282.3% |
| Surmodics, Inc. | 65.82 Million USD | -25.122% |
| iCAD, Inc. | 8 Million USD | -929.359% |
| Nuwellis, Inc. | 6.78 Million USD | -1114.735% |
| Biotricity, Inc. | 35.91 Million USD | -129.288% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 63.075% |
| Aethlon Medical, Inc. | 2.47 Million USD | -3221.396% |
| InspireMD, Inc. | 8.14 Million USD | -911.533% |
| PAVmed Inc. | 57.13 Million USD | -44.143% |
| BIOLASE, Inc. | 35.34 Million USD | -132.995% |
| Beyond Air, Inc. | 29.77 Million USD | -176.605% |
| FONAR Corporation | 57.45 Million USD | -43.339% |
| AxoGen, Inc. | 101.16 Million USD | 18.587% |
| Vivani Medical, Inc. | 25.03 Million USD | -228.962% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 6.193% |
| Inari Medical, Inc. | 209.32 Million USD | 60.655% |
| UFP Technologies, Inc. | 118.04 Million USD | 30.231% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -548.982% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -3667.89% |
| Tenon Medical, Inc. | 5.56 Million USD | -1379.414% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -4529.511% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -367.044% |
| AdaptHealth Corp. | 3.15 Billion USD | 97.388% |
| Sintx Technologies, Inc. | 6.59 Million USD | -1149.189% |
| NanoVibronix, Inc. | 2.68 Million USD | -2966.232% |
| Quanterix Corporation | 78.08 Million USD | -5.475% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2205.683% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -1585.957% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 92.117% |
| TransMedics Group, Inc. | 568.84 Million USD | 85.522% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -393.7% |
| NeuroMetrix, Inc. | 1.33 Million USD | -6077.895% |
| Hyperfine, Inc. | 9.8 Million USD | -740.398% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 67.089% |
| Biomerica, Inc. | 2.66 Million USD | -2992.715% |
| Bone Biologics Corporation | 831.4 Thousand USD | -9806.038% |
| AVITA Medical, Inc. | 19.86 Million USD | -314.585% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -4072.859% |
| Silk Road Medical, Inc | 114.15 Million USD | 27.855% |